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Abstract
Background: Acrokeratosis paraneoplastica is a rare paraneoplastic phenomenon associated with upper
aerodigestive tract carcinomas, usually manifesting as psoriasiform keratosis over the acral sites. It is primarily seen
in white males above the age of 40 years. Here we report a case of paraneoplastic acrokeratosis in a woman with
serous ovarian cancer. To the best of our knowledge, no similar case has been reported previously.
Case presentation: We report the case of a 60-year-old woman diagnosed with a serous ovarian cancer and
complaining of a thickening and peeling of the skin on her feet. Clinical and histological examination, as well as the
course of disease, confirmed the diagnosis of a paraneoplastic plantar keratosis. Under systemic chemotherapy with
carboplatin and paclitaxel the lesion resolved gradually in concordance with tumour marker CA 125.
Conclusions: We present the reported case of paraneoplastic acrokeratosis associated with advanced high-grade
ovarian cancer.
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Background
Acrokeratosis paraneoplastica of Bazex was first described
by Bazex et al. in 1965 [1]. It is a rare acral hyperkeratosis,
most commonly associated with squamous cell carcinoma
of the upper aerodigestive tract or the cervicomediastinal
area [2]. It can precede the diagnosis of the associated
tumour up to 1 year. In most cases, it responds to success-
ful treatment of the underlying tumour and fails to resolve
when the neoplasm persists [3, 4]. In 18 % of patients, cu-
taneous lesions and associated malignancy are diagnosed
concomitantly and in 15 % of the cases the diagnosis of
cancer occurs first. In the remaining 67 % the cutaneous
lesions precede the diagnosis of cancer [5]. The most com-
mon sites of involvement are the ears (79 %), nails (75 %),
nose (63 %), hands (57 %) and feet (50 %). The histopatho-
logical findings are variable and include commonly
acanthosis, psoriasiform epidermal hyperplasia, hyperkera-
tosis and parakeratosis. Sometimes perivascular lympho-
cytic infiltrate and dyskeratotic keratinocytes as well as
vacuolar degeneration in the basal epidermal layer can be
observed [6].
Paraneoplastic acrokeratosis affects primarily Caucasian
men above 40 years of age. A review of 140 cases de-
scribed only 12 cases occuring in women [4, 7].
We present the case of a 60-year-old woman with a
newly diagnosed high-grade serous ovarian cancer and
associated plantar paraneoplastic acrokeratosis. To our
knowledge, the association of this carcinoma with Acro-
keratosis paraneoplastica of Bazex has not been reported
previously.
Case presentation
A 60-year-old woman presented with acute upper abdom-
inal pain, fever, nausea and shivering as well as elevated
liver and pancreatic enzymes. A computed tomographic
scan confirmed the suspicion of lithogenic pancreatitis but
also revealed an unclear mass on both ovaries as well as
signs of peritoneal carcinomatosis, omental cake, infiltra-
tion of the liver and spleen and substantial ascites at the
same time.
CA125 tumour marker was elevated up to 305 U/mL
suggesting the presence of an advanced ovarian cancer
(normal value 0–35 U/mL). No other blood abnormal-
ities beyond high tumour marker levels were found.
Consequently a surgical tumour debulking was per-
formed. Intraoperatively, a highly distinct peritoneal
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carcinomatosis with cementation of all the internal ab-
dominal organs could be seen. The ovaries were buried
under this tumourous mass and couldn’t be fully visua-
lised during the operation. Under these circumstances
no optimal cytoreduction could be performed. The hist-
ology later confirmed the presence of a high-grade serous
carcinoma of the ovary. Chemotherapy with carboplatin
and paclitaxel was induced postoperatively.
Already prior to surgery, approximately when the
ovarian cancer was diagnosed, the patient complained
about a disturbing skin alteration on both her feet. In-
spection revealed laminar hyperkeratosis and scaling of
the plantar skin (enhanced in areas under compressive
stress), which was unbeknownst to her. Dermatological
examination as well as punch biopsy of the skin
(Fig. 1a,b) suggested the presence of a paraneoplastic
acrokeratosis. Histology of plantar skin revealed com-
pact hyperkeratosis and irregular epidermal hyperpla-
sia. Mycosis was excluded histologically. A regression
of the cutaneous lesion together with the normalisation of
the CA125 tumour marker (a drop to 9.3 U/mL) under
first-line chemotherapy containing carboplatin and pacli-
taxel was observed, which further supported the suspected
diagnosis of a paraneoplastic phenomenon (Fig. 2a,b).
Cutaneous eruptions in other areas (eg. face, hands), as
seen in some cases of paraneoplastic acrokeratosis, could
not be found [4, 7].
Discussion
Acrokeratosis paraneoplastica is a rare, obligate paraneo-
plasia initially presenting with palmoplantar hyperkera-
tosis. The pathogenesis is still not well understood. A
few authors have proposed molecular mimicry as a pos-
sible mechanism; the crossed reactions between tumour
antigens and growth factor receptors on epidermal cells.
Another postulated mechanism is the action of epider-
mal growth factor, transforming growth factor-alpha and
insulin-like growth factor secreted by the tumour cells
themselves, which can lead to the cutaneous changes.
Furthermore, zinc deficiency associated with the neo-
plasm may play a role in the pathogenesis of this hyper-
proliferative dermatosis. [2, 8, 9]. Hara et al. formulated
a hypothesis where the pathomechanism of Acrotkerato-
sis paraneoplastica may be related to an immunological
reaction as indicated by multiple factors: association
with tumours always of epidermal and never of mesoder-
mal origin, possible histopathological changes including
the presence of necrotic foci, scattered vacuolar
Fig. 1 Biopsy was taken from the sole of the left foot: Histology of plantar skin showing compact hyperkeratosis and irregular epidermal
hyperplasia without any elements of mycosis; enlarged 10 (a) and 40 (b) times
Fig. 2 Laminar plantar hyperkeratosis on both feet with enhancement of areas under compressive stress (a) before treatment and (b) after three
cycles of chemotherapy (punch marks on left sole)
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degeneration of basal cells, cytoplasmic eosinophilia and
vacuolization of keratinocytes and pigmentary incontin-
ence, which indicate an immunemediated attack on
basal cells. The finding of immunoglobulin and C3 de-
posits on the basement membrane suggests the possibil-
ity of an antibody-initiated immune reaction, possibly
mediated by complement, which provokes an inflamma-
tory response resulting in development of the stated le-
sions [10].
Most cases of paraneoplastic acrokeratosis are associ-
ated with squamous cell carcinomas of the upper one-
third of the respiratory or gastrointestinal tract (i.e. oral
cavity, larynx, lungs, oesophagus). Single case reports also
described an association of acrokeratosis paraneoplastica
with carcinomas of the thymus, bladder, skin, multiple
myeloma, carcinoids, malignant lymphomas and cholan-
giocarcinomas. Women seem to be less affected by acro-
keratosis paranoplastica and only single cases have been
reported in association with gynaecological neoplasms (i.e.
vulva, ductal carcinoma of the breast) [2–4, 9, 11].
Paraneoplastic syndromes are often associated with
ovarian cancers, as determined from a clinicopathological
study of 908 patients in 1992 by Hudson and colleagues
[12]. Few unspecific dermatological conditions were re-
corded. Only one patient was diagnosed with acanthosis
nigricans maligna, the first (rare) dermatosis truly associ-
ated with malignant processes predominantly occurring in
abdominal cancers (90 %), mostly consisting of adenocar-
cinomas. One patient showed dermatomyositis, which af-
fects the skin and muscles. Clinical findings include
malar erythema and poikiloderma on the thorax, associ-
ated with symmetric proximal paresis. Approximately
10–25 % of cases of dermatomyositis are paraneoplastic.
Ovarian, pulmonary, gastric and genital carcinomas are
most frequently correlated [13]. Hudson’s study showed
other findings associated with ovarian carcinoma in-
cluding haematological, neurological, endocrine and
osteoarticular conditions.
In 2011, Fader et al. described the second case (the first
reported in 1983) of Sweet’s syndrome in ovarian carcin-
oma [14]. Sweet’s syndrome or acute febrile neutrophilic
dermatosis is characterized by painful, oedematous, shiny
erythematous nodules or plaques, primarily on the face,
neck, and extremities. Most neoplastic associations involve
haematologic neoplasms [8, 13].
Dermatological signs and symptoms can be common
paraneoplastic manifestations of underlying malignancy.
Cutaneous lesions, typically associated with other neo-
plasms than ovarian carcinoma, are amongst the ones de-
scribed above: Necrolytic migratory erythema (most
commonly associated with islet cell tumours), Paraneo-
plastic Pemphigus (characterized by painful mucosal ero-
sions, ulcerations and polymorphic skin lesions on the
trunk and extremities, associated to lymphoproliferative
disorders), Leser-Trélat sign (sudden onset of seborrheic
keratosis associated with adenocarcinomas of the gastro-
intestinal tract and also lymphoproliferative abnormalities)
and other, more rare dermatoses [13].
Conclusions
To the best of our knowledge, no case of acrokeratosis
paraneoplastica in association with ovarian cancer has
been described before. This is a rare but important para-
neoplastic skin finding to be recognized, as dermatological
symptoms can precede the associated malignancy, unlike
that of our patient.
As the histopathological findings are unspecific, the
diagnosis can only be made on the basis of a combination
of clinical and histological criteria and the regression of
the cutaneous symptoms during and after therapy of the
underlying carcinoma.
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